company background image
IART logo

Integra LifeSciences Holdings Informe acción NasdaqGS:IART

Último precio

US$23.58

Capitalización de mercado

US$1.8b

7D

4.8%

1Y

-39.0%

Actualizada

25 Nov, 2024

Datos

Finanzas de la empresa +

Integra LifeSciences Holdings Corporation

Informe acción NasdaqGS:IART

Capitalización de mercado: US$1.8b

Resumen de acción IART

Integra LifeSciences Holdings Corporation fabrica y vende instrumentos quirúrgicos, productos neuroquirúrgicos y productos para el cuidado de heridas destinados a neurocirugía, cuidados neurocríticos y otorrinolaringología. Saber más

Análisis fundamental de IART
Puntuación del snowflake
Valoración5/6
Crecimiento futuro3/6
Rendimiento pasado0/6
Salud financiera2/6
Dividendos0/6

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

Competidores de Integra LifeSciences Holdings Corporation

Historial de precios y rendimiento

Resumen de todos los máximos históricos, cambios y caídas de precios de Integra LifeSciences Holdings
Precios históricos de las acciones
Precio actual de la acciónUS$23.58
Máximo en las últimas 52 semanasUS$45.42
Mínimo de 52 semanasUS$16.81
Beta1.08
1Cambio en 1 mes24.43%
Variación en 3 meses14.91%
Cambio de 1 año-39.04%
3Variación en 3 años-63.62%
Variación en 5 años-61.22%
Variación desde la OPV409.84%

Noticias y actualizaciones recientes

There's No Escaping Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Muted Revenues Despite A 42% Share Price Rise

Nov 05
There's No Escaping Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Muted Revenues Despite A 42% Share Price Rise

Is Now The Time To Look At Buying Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Oct 24
Is Now The Time To Look At Buying Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Recent updates

There's No Escaping Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Muted Revenues Despite A 42% Share Price Rise

Nov 05
There's No Escaping Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Muted Revenues Despite A 42% Share Price Rise

Is Now The Time To Look At Buying Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Oct 24
Is Now The Time To Look At Buying Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Why Investors Shouldn't Be Surprised By Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Low P/S

Sep 08
Why Investors Shouldn't Be Surprised By Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Low P/S

Is Integra LifeSciences Holdings (NASDAQ:IART) A Risky Investment?

Aug 21
Is Integra LifeSciences Holdings (NASDAQ:IART) A Risky Investment?

At US$29.14, Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Worth Looking At Closely?

Jul 01
At US$29.14, Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Worth Looking At Closely?

Integra LifeSciences Still Underperforming As Manufacturing Issues Linger

Jun 21

Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Intrinsic Value Is Potentially 40% Above Its Share Price

May 28
Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Intrinsic Value Is Potentially 40% Above Its Share Price

Returns On Capital At Integra LifeSciences Holdings (NASDAQ:IART) Have Stalled

Feb 27
Returns On Capital At Integra LifeSciences Holdings (NASDAQ:IART) Have Stalled

We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt

Feb 11
We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt

Is Now An Opportune Moment To Examine Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Jan 14
Is Now An Opportune Moment To Examine Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Price In Tune With Earnings

Dec 31
Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Price In Tune With Earnings

Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 46% Discount?

Dec 03
Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 46% Discount?

Does Integra LifeSciences Holdings (NASDAQ:IART) Have A Healthy Balance Sheet?

Nov 06
Does Integra LifeSciences Holdings (NASDAQ:IART) Have A Healthy Balance Sheet?

Integra LifeSciences Holdings (NASDAQ:IART) Hasn't Managed To Accelerate Its Returns

Oct 24
Integra LifeSciences Holdings (NASDAQ:IART) Hasn't Managed To Accelerate Its Returns

Is Now An Opportune Moment To Examine Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Sep 22
Is Now An Opportune Moment To Examine Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 38% Discount?

Aug 15
Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 38% Discount?

Returns On Capital At Integra LifeSciences Holdings (NASDAQ:IART) Have Hit The Brakes

Jul 03
Returns On Capital At Integra LifeSciences Holdings (NASDAQ:IART) Have Hit The Brakes

Is There Now An Opportunity In Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Jun 19
Is There Now An Opportunity In Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Estimating The Fair Value Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)

May 05
Estimating The Fair Value Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)

These 4 Measures Indicate That Integra LifeSciences Holdings (NASDAQ:IART) Is Using Debt Reasonably Well

Apr 07
These 4 Measures Indicate That Integra LifeSciences Holdings (NASDAQ:IART) Is Using Debt Reasonably Well

Integra LifeSciences Holdings (NASDAQ:IART) Is Experiencing Growth In Returns On Capital

Mar 26
Integra LifeSciences Holdings (NASDAQ:IART) Is Experiencing Growth In Returns On Capital

At US$52.61, Is It Time To Put Integra LifeSciences Holdings Corporation (NASDAQ:IART) On Your Watch List?

Mar 14
At US$52.61, Is It Time To Put Integra LifeSciences Holdings Corporation (NASDAQ:IART) On Your Watch List?

Does Integra LifeSciences Holdings (NASDAQ:IART) Deserve A Spot On Your Watchlist?

Feb 27
Does Integra LifeSciences Holdings (NASDAQ:IART) Deserve A Spot On Your Watchlist?

Calculating The Fair Value Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)

Feb 02
Calculating The Fair Value Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)

We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt

Jan 05
We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt

Here's What To Make Of Integra LifeSciences Holdings' (NASDAQ:IART) Decelerating Rates Of Return

Dec 21
Here's What To Make Of Integra LifeSciences Holdings' (NASDAQ:IART) Decelerating Rates Of Return

When Should You Buy Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Dec 08
When Should You Buy Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Rentabilidad de los accionistas

IARTUS Medical EquipmentMercado US
7D4.8%1.5%2.2%
1Y-39.0%20.8%31.6%

Rentabilidad vs. Industria: Los resultados de IART fueron inferiores a los de la industria US Medical Equipment, que obtuvo un rendimiento del 20.8% el año pasado.

Rentabilidad vs. Mercado: IART obtuvo unos resultados inferiores a los del mercado US, que fueron del 31.6% el año pasado.

Volatilidad de los precios

Is IART's price volatile compared to industry and market?
IART volatility
IART Average Weekly Movement9.0%
Medical Equipment Industry Average Movement8.1%
Market Average Movement6.3%
10% most volatile stocks in US Market15.7%
10% least volatile stocks in US Market3.1%

Precio estable de las acciones: IART no ha tenido una volatilidad de precios significativa en los últimos 3 meses.

Volatilidad a lo largo del tiempo: La volatilidad semanal de IART (9%) se ha mantenido estable durante el año pasado.

Acerca de la empresa

FundadaEmpleadosCEOPágina web
19893,946Jan De Wittewww.integralife.com

Integra LifeSciences Holdings Corporation fabrica y vende instrumentos quirúrgicos, productos neuroquirúrgicos y productos para el cuidado de heridas destinados a neurocirugía, cuidados neurocríticos y otorrinolaringología. Opera en dos segmentos, Codman Specialty Surgical y Tissue Technologies. La empresa ofrece productos de neurocirugía y cuidados neurocríticos, incluidos equipos de ablación tisular, productos de reparación dural, dispositivos de gestión del líquido cefalorraquídeo, equipos de monitorización intracraneal y equipos de estabilización craneal; y lámparas frontales e instrumentación quirúrgica, así como servicios posventa.

Resumen de fundamentos de Integra LifeSciences Holdings Corporation

¿Cómo se comparan los beneficios e ingresos de Integra LifeSciences Holdings con su capitalización de mercado?
Estadísticas fundamentales de IART
Capitalización bursátilUS$1.82b
Beneficios(TTM)-US$6.54m
Ingresos (TTM)US$1.56b

1.2x

Ratio precio-ventas (PS)

-278.0x

Ratio precio-beneficio (PE)

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de IART
IngresosUS$1.56b
Coste de los ingresosUS$632.40m
Beneficio brutoUS$932.52m
Otros gastosUS$939.06m
Beneficios-US$6.54m

Últimos beneficios comunicados

Sep 30, 2024

Próxima fecha de beneficios

n/a

Beneficios por acción (BPA)-0.085
Margen bruto59.59%
Margen de beneficio neto-0.42%
Ratio deuda/patrimonio118.9%

¿Cómo se ha desempeñado IART a largo plazo?

Ver rendimiento histórico y comparativa